These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23902855)

  • 21. Safety of antiretroviral prophylaxis of perinatal transmission for HIV-infected pregnant women and their infants.
    Mofenson LM; Munderi P
    J Acquir Immune Defic Syndr; 2002 Jun; 30(2):200-15. PubMed ID: 12045684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to reverse transcriptase inhibitors used in the treatment and prevention of HIV-1 infection.
    Sluis-Cremer N; Wainberg MA; Schinazi RF
    Future Microbiol; 2015; 10(11):1773-82. PubMed ID: 26517190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations: current considerations in light of new findings.
    Myers GM; Mayer KH
    AIDS Patient Care STDS; 2011 Feb; 25(2):63-71. PubMed ID: 21284497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
    Dorenbaum A; Cunningham CK; Gelber RD; Culnane M; Mofenson L; Britto P; Rekacewicz C; Newell ML; Delfraissy JF; Cunningham-Schrader B; Mirochnick M; Sullivan JL;
    JAMA; 2002 Jul; 288(2):189-98. PubMed ID: 12095383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pregnancy: a model of prevention of HIV transmission].
    Mandelbrot L
    Bull Acad Natl Med; 2014; 198(4-5):813-24. PubMed ID: 26753411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treating the HIV-infected pregnant woman and her child.
    Pitt J; Cotton D
    AIDS Clin Care; 1997 Dec; 9(12):91-3, 95. PubMed ID: 11364840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New studies of methods for preventing perinatal HIV transmission.
    Hanna L
    BETA; 1997 Mar; ():20. PubMed ID: 11364523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretrovirals and safer conception for HIV-serodiscordant couples.
    Matthews LT; Smit JA; Cu-Uvin S; Cohan D
    Curr Opin HIV AIDS; 2012 Nov; 7(6):569-78. PubMed ID: 23032734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R; Paredes R; Parboosing R; Moodley P; Singh L; Naidoo A; Gordon M
    J Med Virol; 2015 Oct; 87(10):1662-7. PubMed ID: 25940687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New drug regimen helps prevent HIV infection in infants.
    Health Care Financ Rev; 1999; 21(1):134-5. PubMed ID: 11481728
    [No Abstract]   [Full Text] [Related]  

  • 32. Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission.
    Olson SC; Ngo-Giang-Huong N; Beck I; Deng W; Britto P; Shapiro DE; Bumgarner RE; Mullins JI; Van Dyke RB; Jourdain G; Frenkel LM
    AIDS; 2015 Jul; 29(12):1467-71. PubMed ID: 26244386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.
    Bardsley-Elliot A; Perry CM
    Paediatr Drugs; 2000; 2(5):373-407. PubMed ID: 11022799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The economics, financing and implementation of HIV treatment as prevention: what will it take to get there?
    Wilson D; Taaffe J; Fraser-Hurt N; Gorgens M
    Afr J AIDS Res; 2014; 13(2):109-19. PubMed ID: 25174628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral Medications for the Prevention of HIV Infection: A Clinical Approach to Preexposure Prophylaxis, Postexposure Prophylaxis, and Treatment as Prevention.
    Heendeniya A; Bogoch II
    Infect Dis Clin North Am; 2019 Sep; 33(3):629-646. PubMed ID: 31239092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Spaulding A; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2010 Oct; (10):CD008740. PubMed ID: 20927777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
    PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NRTI backbone in HIV treatment: will it remain relevant?
    Tressler R; Godfrey C
    Drugs; 2012 Nov; 72(16):2051-62. PubMed ID: 23083109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission.
    Bhoopat L; Khunamornpong S; Lerdsrimongkol P; Sirivatanapa P; Sethavanich S; Limtrakul A; Gomutbuthra V; Kajanavanich S; Thorner PS; Bhoopat T
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):545-50. PubMed ID: 16284530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should we fear resistance from tenofovir/emtricitabine preexposure prophylaxis?
    Parikh UM; Mellors JW
    Curr Opin HIV AIDS; 2016 Jan; 11(1):49-55. PubMed ID: 26633640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.